Comparing the TDTP-RECIST With RECIST 1.1 and Other Volumetric Evaluation Methods for Assessing the Therapeutic Efficacy of Irregular Malignant Tumors

Clinical trial NCT07319767 · COMPLETED

Trial details

NCT number: NCT07319767
Sponsor: Shanghai Zhongshan Hospital
Status: COMPLETED
Study type: OBSERVATIONAL

Breast Cancer Pancreatic Adenocarcinoma (Ductal Adenocarcinoma)Biliary Cancer (Cholangiocarcinoma, Gall Bladder Cancer)

Start date: 2024-05-14
Primary completion: 2025-07-05
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.